Imagenebio Stock Alpha and Beta Analysis

IMA Stock   6.58  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as ImageneBio. It also helps investors analyze the systematic and unsystematic risks associated with investing in ImageneBio over a specified time horizon. Remember, high ImageneBio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to ImageneBio's market risk premium analysis include:
Beta
(0.43)
Alpha
(0.20)
Risk
3.64
Sharpe Ratio
(0.03)
Expected Return
(0.11)
Please note that although ImageneBio alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, ImageneBio did 0.20  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of ImageneBio stock's relative risk over its benchmark. ImageneBio has a beta of 0.43  . As returns on the market increase, returns on owning ImageneBio are expected to decrease at a much lower rate. During the bear market, ImageneBio is likely to outperform the market. At present, ImageneBio's Book Value Per Share is projected to slightly grow based on the last few years of reporting. The current year's Tangible Book Value Per Share is expected to grow to 2.47, whereas Enterprise Value Over EBITDA is forecasted to decline to (24.45).

Enterprise Value

958.63 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out ImageneBio Backtesting, ImageneBio Valuation, ImageneBio Correlation, ImageneBio Hype Analysis, ImageneBio Volatility, ImageneBio History and analyze ImageneBio Performance.
For information on how to trade ImageneBio Stock refer to our How to Trade ImageneBio Stock guide.

ImageneBio Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. ImageneBio market risk premium is the additional return an investor will receive from holding ImageneBio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ImageneBio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate ImageneBio's performance over market.
α-0.2   β-0.43

ImageneBio expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of ImageneBio's Buy-and-hold return. Our buy-and-hold chart shows how ImageneBio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

ImageneBio Market Price Analysis

Market price analysis indicators help investors to evaluate how ImageneBio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ImageneBio shares will generate the highest return on investment. By understating and applying ImageneBio stock market price indicators, traders can identify ImageneBio position entry and exit signals to maximize returns.

ImageneBio Return and Market Media

The median price of ImageneBio for the period between Fri, Oct 17, 2025 and Thu, Jan 15, 2026 is 7.11 with a coefficient of variation of 11.65. The daily time series for the period is distributed with a sample standard deviation of 0.84, arithmetic mean of 7.24, and mean deviation of 0.73. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
This Albemarle Analyst Begins Coverage On A Bullish Note Here Are Top 5 Initiations For Friday
10/24/2025
2
Image Resources AU11m Market Cap Fall Books Insider Losses
10/30/2025
3
Insider Trading
10/31/2025
4
Closing Bell Banks coax ASX back to neutral to dodge fifth day of losses
11/03/2025
5
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Stren...
11/12/2025
6
Brokerages Set ImageneBio, Inc. Target Price at 26.50
11/25/2025
7
Acquisition by Slattery Joseph P of 16000 shares of ImageneBio at 5.99 subject to Rule 16b-3
12/24/2025
8
Acquisition by Erin Butler of 22500 shares of ImageneBio at 7.11 subject to Rule 16b-3
12/30/2025
9
ImageneBio Insider Confidence Rewarded, Stock Hits US76m Market Cap
12/31/2025
10
Breaking News IMA Senior Fellow Dr. Kimberly Biss Appointed to Advisory Committee on Immunization Practices
01/13/2026

About ImageneBio Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including ImageneBio or other stocks. Alpha measures the amount that position in ImageneBio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2025 2026 (projected)
Interest Debt Per Share0.260.180.17
Revenue Per Share0.220.08340.0792
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ImageneBio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ImageneBio's short interest history, or implied volatility extrapolated from ImageneBio options trading.

Build Portfolio with ImageneBio

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether ImageneBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ImageneBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Imagenebio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Imagenebio Stock:
Check out ImageneBio Backtesting, ImageneBio Valuation, ImageneBio Correlation, ImageneBio Hype Analysis, ImageneBio Volatility, ImageneBio History and analyze ImageneBio Performance.
For information on how to trade ImageneBio Stock refer to our How to Trade ImageneBio Stock guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
ImageneBio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ImageneBio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ImageneBio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...